TCRT - Alaunos Therapeutics, Inc.
Previous close
1.74
0.040 2.299%
Share volume: 21,765
Last Updated: Mon 13 Jan 2025 10:00:00 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$1.70
0.04
0.02%
View ratios
| Fiscal Date | 2024-03-31 | 2024-06-30 | 2024-09-30 | |
|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | |
| Report Date | 2024-05-15 | 2024-08-14 | 2024-11-14 | |
| Total revenue | 1.000 K | 4.000 K | 0.000 | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | |
| Gross profit | 1.000 K | 4.000 K | 0.000 | |
| 300.00% | -100.00% | |||
| Operating expenses | 1.743 M | 1.170 M | 1.150 M | |
| Selling general and admin | 1.617 M | 990.000 K | 1.007 M | |
| Research and development | 126.000 K | 180.000 K | 143.000 K | |
| Total expenses | 1.743 M | 1.170 M | 1.150 M | |
| -32.87% | -1.71% | |||
| Operating income | -1.742 M | -1.166 M | -1.150 M | |
| Ebit | -1.682 M | -1.129 M | -1.127 M | |
| Pretax income | -1.682 M | -1.129 M | -1.127 M | |
| -32.88% | -0.18% | |||
| Income tax | 0.000 | 0.000 | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | |
| Net income | -1.682 M | -1.129 M | -1.127 M | |
| 32.88% | 0.18% |